FDA Clears Masimo Brain Function Monitoring Device

January 31, 2018

The FDA cleared the SedLine brain function monitoring device from Masimo.

“SedLine helps clinicians monitor the state of the brain under anesthesia with bilateral acquisition and processing of four lead of electroencephalogram (ECG) signals,” Masimo said.

The device uses a signal processing engine to provide clinicians a complete picture of a patient’s brain representing activity in both sides.

View today's stories